🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Research Progress of Renal Denervation in the Treatment of Refractory Hypertension
Abstract:Hypertension is a disease with high incidence and increasing prevalence, which is prone to cause cardiovascular complications. Although various antihypertensive drugs have been developed, the blood pressure control rate among hypertensive patients remains low; in view of this, the 2024 edition of the Chinese Guidelines for the Prevention and Treatment of Hypertension emphasizes the need to strengthen and actively control blood pressure. Refractory hypertension is a special type of hypertension, in which patients' blood pressure remains uncontrolled even after using ≥5 antihypertensive drugs (including thiazide diuretics and aldosterone receptor antagonists), and it is often accompanied by severe target organ damage. It is estimated that 8% to 30% of hypertensive patients suffer from refractory hypertension, which has always been a major challenge for clinicians due to its difficult treatment [1].
Keywords:HypertensionGanglionSympatheticRenal Artery
Publication Date:2025-06-15
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:3( 819-821 )